| European Case Law Identifier: | ECLI:EP:BA:2001:T018897.20010208 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 08 February 2001 | ||||||||
| Case number: | T 0188/97 | ||||||||
| Application number: | 88310922.5 | ||||||||
| IPC class: | C12N 15/00 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | NANBV diagnostics and vaccines | ||||||||
| Applicant name: | CHIRON CORPORATION, et al | ||||||||
| Opponent name: | (4) Dade Behring Marburg GmbH (5) The Research Foundation for Microbial Diseases of Osaka (6) F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft |
||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: | |||||||||
| Keywords: | Admissibility of the interventions (no) Admissibility of Appellant's II appeal (yes) Main request - added subject-matter (yes) Auxiliary requests A to D - sufficiency of disclosure (no) Auxiliary request E - inventive step (yes) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: | |||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t970188eu1.html
Date retrieved: 17 May 2021
